2Halstensen T. Epithelial deposition of immunogolbulin Gr and activated complement Ic3b and Terminal complement complex I in ulcerative colitis.Gastroenterology, 1990; 98: 1264
3Freeman H, Roecd B, Devine D,et al. Prospective evaluation of antineutrophil autoantibodise in 500 consecutive patients with inflammatory bowel disease. Can J Gastroenterol, 1997; 11 : 203
4Binion DG, West GA, Ina K, et al. Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease.Gastroenterology, 1997 ; 112 : 1895
5Vincenzo CR, Lori K, Yoojin TC, et al. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. J Immunol, 1995; 154:2434
6Holtkamp W, Stollberg T, Reis HE. Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease. J Clin Gastroenterol, 1995; 20(2) : 123
7Holub MC, Mako E, Devay T, et al. Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease. Scand J Gastroenterol,1998;228 : (33 Suppl) 47
8Grottrup-Wolfers E, Moeller J, Karbach U, et al.Elevated cell-associated levels of interleukin 1β and interleukin 6 in inflamed mucosa of inflammatory bowel disease. Eur J Cli Invest, 1996; 26 : 115
9Kazuo K,Atsushi F, Mitsune T, et al. Elevation of interleukin-6 in inflammatory bowel disease is macrophage-and epithelial cell-dependent. Kig Kis Sci, 1995; 40(5) : 949
10Taniguchi T, Tsukada H, Nadamura H, et al.Effects of the anti-ICAM-1 monocloned antibody on dextran sodium sulphate induced colitis in rats. J Gastroenterol-Hepatol, 1998 ; 13 : 945
